Sign in

CIK 0001601830

  • Large accelerated filer

RECURSION PHARMACEUTICALS, INC.

Sign in to watch
Ticker
RXRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464099738
Phone
+1 385-269-0203
Business address
41S RIO GRANDE STREET, SALT LAKE CITY, UT, 84101
Former names
Recursion Pharmaceuticals, LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$701,222
in 5 filings, $701K under 10b5-1 plans

Net −$701,222. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-01-03 Gibson Christopher Chief Executive Officer Exercise or conversion · Stock Option (Right to Buy) −31,250 375,000
2024-01-03 Gibson Christopher Chief Executive Officer Conversion · Class B Common Stock −10,000 6,481,496
2024-01-03 Gibson Christopher Chief Executive Officer Conversion · Class B Common Stock −4,000 515,000
2024-01-03 Gibson Christopher Chief Executive Officer Conversion · Class B Common Stock −20,000 408,000
2024-01-03 Gibson Christopher Chief Executive Officer Conversion · Class B Common Stock −1,000 118,875
2024-01-02 CHAVEZ R. MARTIN Director Grant or award +1,900 58,077
2024-01-02 Dar Zavain Director Grant or award +1,393 55,216
2024-01-02 Li Dean Y Director Grant or award +1,203 1,327,618
2023-12-28 Larson Tina Marriott President and COO Exercise or conversion 10b5-1 +8,000 $1.06 $8K 422,548
2023-12-28 Larson Tina Marriott President and COO Sale 10b5-1 −8,000 $10.58 $85K 414,548
2023-12-28 Larson Tina Marriott President and COO Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −8,000 512,000
2023-12-26 Borgeson Blake Director Sale 10b5-1 −20,054 $10.63 $213K 7,364,472
2023-12-15 Virani Shafique Chief Business Officer Exercise or conversion 10b5-1 +18,000 $2.22 $40K 154,748
2023-12-15 Virani Shafique Chief Business Officer Sale 10b5-1 −18,000 $9.60 $173K 136,748
2023-12-15 Virani Shafique Chief Business Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −18,000 379,469
2023-12-14 Dar Zavain Director Sale 10b5-1 −20,141 $9.00 $181K 53,823
2023-12-13 Secora Michael Chief Financial Officer Exercise or conversion 10b5-1 +37,500 $2.22 $83K 981,014
2023-12-13 Secora Michael Chief Financial Officer Sale 10b5-1 −25,000 $7.59 $190K 956,014
2023-12-13 Secora Michael Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −37,500 1,110,135
2023-12-12 Secora Michael Chief Financial Officer Exercise or conversion 10b5-1 +37,500 $2.22 $83K 968,514

Page 27 of 41 · 805 trades